- Home
- SONN vs RVP Comparison
SONN vs RVP Comparison
Compare SONN & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- RVP
- Stock Information
- Founded
- SONN N/A
- RVP 1994
- Country
- SONN United States
- RVP United States
- Employees
- SONN N/A
- RVP N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- RVP Medical/Dental Instruments
- Sector
- SONN Health Care
- RVP Health Care
- Exchange
- SONN Nasdaq
- RVP Nasdaq
- Market Cap
- SONN 21.4M
- RVP 25.1M
- IPO Year
- SONN N/A
- RVP 2001
- Fundamental
- Price
- SONN $5.90
- RVP $0.82
- Analyst Decision
- SONN Strong Buy
- RVP
- Analyst Count
- SONN 1
- RVP 0
- Target Price
- SONN $20.00
- RVP N/A
- AVG Volume (30 Days)
- SONN 825.4K
- RVP 77.0K
- Earning Date
- SONN 08-13-2025
- RVP 11-13-2025
- Dividend Yield
- SONN N/A
- RVP N/A
- EPS Growth
- SONN N/A
- RVP N/A
- EPS
- SONN N/A
- RVP N/A
- Revenue
- SONN $1,000,000.00
- RVP $38,161,712.00
- Revenue This Year
- SONN $5,376.22
- RVP N/A
- Revenue Next Year
- SONN N/A
- RVP N/A
- P/E Ratio
- SONN N/A
- RVP N/A
- Revenue Growth
- SONN 1689.52
- RVP N/A
- 52 Week Low
- SONN $1.08
- RVP $0.56
- 52 Week High
- SONN $19.30
- RVP $0.94
- Technical
- Relative Strength Index (RSI)
- SONN 74.18
- RVP 57.28
- Support Level
- SONN $2.71
- RVP $0.79
- Resistance Level
- SONN $4.35
- RVP $0.83
- Average True Range (ATR)
- SONN 0.58
- RVP 0.03
- MACD
- SONN 0.22
- RVP -0.00
- Stochastic Oscillator
- SONN 80.96
- RVP 55.56
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.